Stock Price
45.48
Daily Change
-1.06 -2.28%
Monthly
-4.01%
Yearly
-13.70%
Q1 Forecast
44.07

Recordati reported EUR171.38M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
GlaxoSmithKline GBP 2.68B 518M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Orion EUR 110.7M 26.1M Dec/2025
Sanofi EUR 2.75B 455M Dec/2025